Coya Therapeutics (COYA) Other Non-Current Assets (2021 - 2022)
Coya Therapeutics (COYA) reported Other Non-Current Assets of $1.1 million for Q4 2022, up 1181.58% on a YoY basis from $87181.0 in Q4 2021, and up 1181.58% sequentially from $87181.0 in Q4 2021.
Coya Therapeutics (COYA) Other Non-Current Assets (2021 - 2022) Analysis & Trends
Coya Therapeutics (COYA) has 2 years of Other Non-Current Assets data on file, last reported at $1.1 million in Q4 2022.
- For the quarter ending Q4 2022, Other Non-Current Assets rose 1181.58% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2022 stood at $1.1 million (up 1181.58% YoY), and the FY2022 full-year result was $1.1 million, up 1181.58% from the prior year.
- Other Non-Current Assets climbed to $1.1 million in Q4 2022, from $87181.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.1 million in Q4 2022 to a low of $87181.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 87,181.00 |